Dr. Henningfield: "Dr. Henningfield is a Principal at, and derives most of his income from, Pinney Associates, a firm that currently provides to GSK on an exclusive basis consulting services regarding smoking-cessation products. His formal title is: Vice President, Research & Health Policy. Through his association with Pinney Associates, Dr. Henningfield advises GSK specifically on the development of nicotine-replacement therapies and treatments for tobacco dependence. Pinney Associates has received on average more than $2 million per year in revenue from pharmaceutical companies, more than half of which relates to smoking-cessation products. In addition, during the last decade, Dr. Henningfield has received grant support for research and writing from GSK on at least eight occasions. Dr. Henningfield is also a partner in a company that holds patents for a nicotine replacement-therapy product. He has estimated that, if thess patents are successfully licensed, they could be worth more than $1 million to him as a partner in that company. Thus, Dr. Henningfield has a financial interest in bringing about regulatory policies that will drive current smokers to use nicotine-replacement-therapy products."

• The truth is that the study only measured ever use of electronic cigarettes, not current use, regular use, or addiction to nicotine. Thus, it could not determine whether the kids who had tried electronic cigarettes ever used them again. So it could not tell if these kids were addicted to nicotine. They may have simply tried an electronic cigarette and not vaped again.

Fortunately, I'm used to this treatment, so I'm not going to be bullied into backing down. I believe that a lot is at stake here, because a wrong move on the part of the FDA in banning filtered cigarettes could literally lead to an increase in cigarette-related deaths.

LAST：2013 hottest pcc electronic cigarettes |NEXT：Hot selling hammer mod e cig Big Vapor Ecig Stainless Steel Clone